Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients (Q72354142)
Jump to navigation
Jump to search
scientific article published on 01 January 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients |
scientific article published on 01 January 1995 |
Statements
Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients (English)
D Abigerges
G G Chabot
J P Armand
P Hérait
A Gouyette
1 January 1995